AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions

AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions

Introduction: Cervical dystonia (CD) is a neurologic movement disorder with potentially disabling effects and significant impact on quality of life of those affected. AbobotulinumtoxinA (aboBoNT-A) was initially approved for a dilution of 500 U/1 mL and subsequently for a dilution of 500 U/2 mL, pro...

Full description

Bibliographic Details
Main Authors: Mark F. Lew, Robert A. Hauser, Stuart H. Isaacson, Daniel Truong, Atul T. Patel, Allison Brashear, William Ondo, Pascal Maisonobe, Khashayar Dashtipour, Laxman Bahroo, Stefan Wietek
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Clinical Parkinsonism & Related Disorders
Subjects:
AbobotulinumtoxinA
Cervical dystonia
Dosing flexibility
Dilution
Treatment
Online Access:http://www.sciencedirect.com/science/article/pii/S259011252100027X

Internet

http://www.sciencedirect.com/science/article/pii/S259011252100027X

Similar Items